Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Companies are spending on technology again. Ness Technologies (NSTC) recently announced record quarterly revenue. This Zacks #1 Rank (strong buy) also has attractive valuations, with a price-to-sales ratio of just 0.4.
Ness Technologies is an Israeli-based provider of IT and business services and consulting. It specializes in software product engineering and enterprise applications services.
The company has operations in North America, Europe, India and Israel and customers in 20 countries.
Won Barclays Contract
On Mar 15, Ness announced it had won a contract with Barclays Capital, which is the investment banking arm of Barclays Bank, to establish an Israel Development and Engineering Center. The Center would provide technology development and engineering services.
The contract is worth $75 million over 5 years.
Ness Surprised By 240% in the Fourth Quarter
Ness reported its fourth quarter and full year results on Feb 2 and easily blew by the Zacks Consensus Estimate by 12 cents. Earnings per share were 17 cents compared to the consensus of just 5 cents. The company made 8 cents in the year ago quarter.
This was the 7th earnings surprise in a row.
Revenue jumped 16% to a quarterly record of $157.4 million. For the year, revenue climbed 12% to $571.8 million.
Both of the company's segments saw increased revenue in the fourth quarter. System Integration and Application Development also saw improvement in Central and Eastern Europe.
In Central and Eastern Europe, for both segments, operating margin hit the highest level in 8 quarters as it continued to recover.
Outlook for 2011
Ness expects top line growth and operating margin expansion in 2011.
Revenue is projected to be in the range of $595 million to $605 million. Earnings per share are expected between 42 and 48 cents.
Zacks Consensus Estimates Rise
While the 2011 Zacks Consensus Estimate jumped to 44 cents from 33 cents in the last 2 months on the company's guidance, this is still 3.6% under the 46 cents earned in 2010.
Earnings growth is expected to return in earnest in 2012 as analysts project earnings growth of 25.2% to 56 cents.
Ness is expected to report first quarter results on Apr 27.
Lots of Value in Ness
In addition to the low P/S ratio, Ness also has other value characteristics.
The company is trading with a forward P/E of 13.6, which is under my cut-off of 15x for "value".
It also has a really low price-to-book of 0.7, under the 3.0 usually used for a "value" P/B ratio.
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor in charge of the market-beating Zacks Value Trader service. You can follow her at twitter.com/traceyryniec.